The IM Decision Making And Problem-Solving Model: A Unisex Context
نویسندگان
چکیده
منابع مشابه
Decision Making and Problem Solving
| 994 | haematologica | 2009; 94(7) Acknowledgments: we want to address our warm thanks to Kathy Heptinstall and to the MDS-Foundation for their technical support in the organization of meetings. We have special thanks for Alain Renault (University Hospital of Rennes) who provided assistance for statistical evaluation. Manuscript received on December 31, 2008. Revised version arrived on Februar...
متن کاملDecision Making and Problem Solving
Caring for a child with sickle cell disease poses extra demands on parents, both practically and psychologically, which may influence their quality of life. Since families of children with sickle cell disease in the Netherlands usually belong to immigrant communities with a low socio-economic status, there may be an additional strain on caregivers. The aim of the present study was to evaluate t...
متن کاملDecision Making and Problem Solving
Acute myeloid leukemia with mutated NPM1 gene and aberrant cytoplasmic expression of nucleophosmin (NPMc acute myeloid leukemia) shows distinctive biological and clinical features. Experimental evidence of the oncogenic potential of the nucleophosmin mutant is, however, still lacking, and it is unclear whether other genetic lesion(s), e.g. FLT3 internal tandem duplication, cooperate with NPM1 m...
متن کاملDecision Making and Problem Solving
New measures of iron accumulation in liver and heart (superconducting quantum inference device and magnetic resonance imaging), and oral iron chelators (deferiprone and deferasirox) are available for managing iron overload in thalassemia major. To assure appropriate use of these new health technologies, the Italian Society of Hematology appointed a panel of experts to produce clinical practiceg...
متن کاملDecision Making and Problem Solving
haematologica | 2009; 94(10) | 1435 | The standard phase III trial These trials typically randomize approximately 400 patients between two therapies. This relatively large number is required to detect relatively small improvements with a false positive rate less than 5% (p<0.05) and a false negative rate less than 20% (80% power). For example, the trials in references 1-3 targeted increases in ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Management Theory and Practice (JMTP)
سال: 2020
ISSN: 2716-7089
DOI: 10.37231/jmtp.2020.1.3.45